Page last updated: 2024-08-24

adamantylamide-alanyl-isoglutamine and Orthomyxoviridae Infections

adamantylamide-alanyl-isoglutamine has been researched along with Orthomyxoviridae Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masek, K; Masihi, KN; Palache, B; Rohde-Schulz, B1
Gast, G; Huchshorn, P; Lange, W; Masek, K; Masihi, KN; Palache, A; Schwenke, S1

Reviews

1 review(s) available for adamantylamide-alanyl-isoglutamine and Orthomyxoviridae Infections

ArticleYear
Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide.
    Advances in experimental medicine and biology, 1992, Volume: 319

    Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Dipeptides; Hypersensitivity, Delayed; Immunity, Cellular; Influenza Vaccines; Mice; Orthomyxoviridae Infections

1992

Other Studies

1 other study(ies) available for adamantylamide-alanyl-isoglutamine and Orthomyxoviridae Infections

ArticleYear
Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection.
    Vaccine, 1990, Volume: 8, Issue:2

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aerosols; Aluminum Hydroxide; Amantadine; Animals; Antibodies, Viral; Cross Reactions; Dipeptides; Female; Hemagglutination Inhibition Tests; Influenza A virus; Influenza B virus; Influenza Vaccines; Mice; Orthomyxoviridae Infections; Vaccination

1990